학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 156건 | 목록 1~20
Academic Journal
Krossa I; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Pisibon C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Cheli Y; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Bille K; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Dalmasso M; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Hamadat S; CNRS UMR9019 Genome Integrity and Cancers, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Inovarion, Paris, 75005, France.; Husser C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Irondelle M; University Côte d'Azur, Nice, France.; Cherfils-Vicini J; University Côte d'Azur, Nice, France.; Centre National de la Recherche Scientifique (CNRS) UMR7284, Inserm U1081, Institute for Research on Cancer and Aging, Nice (IRCAN), Nice, 06107, France.; Soysouvanh F; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Nahon-Esteve S; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Department of Ophthalmology, Centre Hospitalier Universitaire of Nice, Nice, France.; Martel A; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Department of Ophthalmology, Centre Hospitalier Universitaire of Nice, Nice, France.; Lassalle S; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Laboratory of Clinical and Experimental Pathology (LPCE), Biobank BB-0033-00025, Nice, France.; Caujolle JP; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Department of Ophthalmology, Centre Hospitalier Universitaire of Nice, Nice, France.; Maschi C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Department of Ophthalmology, Centre Hospitalier Universitaire of Nice, Nice, France.; Baillif S; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Department of Ophthalmology, Centre Hospitalier Universitaire of Nice, Nice, France.; Hasson D; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Core, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Carcamo S; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Core, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Aplin AE; Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Davidson I; IGBMC, CNRS UMR7104, INSERM U1258, Université de Strasbourg, Illkirch, France.; Bernstein E; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Naim V; CNRS UMR9019 Genome Integrity and Cancers, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Ballotti R; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Bertolotto C; University Côte d'Azur, Nice, France. Corine.Bertolotto@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France. Corine.Bertolotto@univ-cotedazur.fr.; Strub T; University Côte d'Azur, Nice, France. thomas.strub@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2025 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, Nice, France. thomas.strub@univ-cotedazur.fr.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Academic Journal
Fricker J; Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, 103, Grande Rue de la Croix-Rousse, Lyon, 69317, France.; Nahon-Esteve S; Service d'Ophtalmologie, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, 06000, France.; INSERM, Biologie et Pathologies des mélanocytes, équipe 1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, 06200, France.; Tick S; Service Oncopole, Hôpital National de la Vision des 15-20, Paris, 75571, France.; Nhari M; Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, 103, Grande Rue de la Croix-Rousse, Lyon, 69317, France.; Chotard G; Service Oncopole, Hôpital National de la Vision des 15-20, Paris, 75571, France.; Nguyen AM; Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, 103, Grande Rue de la Croix-Rousse, Lyon, 69317, France.; Centre Ophtalmologique Pôle Vision Val d'Ouest, Lyon, France.; Baillif S; Service d'Ophtalmologie, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, 06000, France.; Kodjikian L; Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, 103, Grande Rue de la Croix-Rousse, Lyon, 69317, France.; Laboratoire MATEIS, UMR-CNRS 5510, INSA, Université Claude Bernard, Lyon 1, Villeurbanne, 69100, France.; Mathis T; Service d'Ophtalmologie, Hôpital Universitaire de la Croix-Rousse, Hospices Civils de Lyon, 103, Grande Rue de la Croix-Rousse, Lyon, 69317, France. thibaud.mathis@chu-lyon.fr.; Laboratoire MATEIS, UMR-CNRS 5510, INSA, Université Claude Bernard, Lyon 1, Villeurbanne, 69100, France. thibaud.mathis@chu-lyon.fr.
Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 8205248 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-702X (Electronic) Linking ISSN: 0721832X NLM ISO Abbreviation: Graefes Arch Clin Exp Ophthalmol Subsets: MEDLINE
Academic Journal
Nahon-Estève S; Université Côte d'Azur, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Service d'Ophtalmologie, Nice, France; Institut National de la Santé et de la Recherche Médicale U1065, Biology and Pathologies of Melanocytes, Team 1, Centre Méditerranéen de Médecine Moléculaire, Nice, France.; Caujolle JP; Université Côte d'Azur, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Service d'Ophtalmologie, Nice, France.; Maschi C; Université Côte d'Azur, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Service d'Ophtalmologie, Nice, France.; Navaratnam J; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; Krohn J; Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway.; Eide NA; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; Kiliç E; Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, Rotterdam, The Netherlands.; Brosens E; Department of Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, Rotterdam, The Netherlands.; Bassil FL; Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, Rotterdam, The Netherlands.; Rospond-Kubiak I; Department of Ophthalmology, Poznan University of Medical Sciences, Poznán, Poland.; Krasińska-Płachta A; Department of Ophthalmology, Poznan University of Medical Sciences, Poznán, Poland.; Sonntag SR; Department of Ophthalmology, University Medical Center Schleswig-Holstein, University of Lübeck, Lübeck, Germany.; Tura A; Department of Ophthalmology, University Medical Center Schleswig-Holstein, University of Lübeck, Lübeck, Germany.; Grisanti S; Department of Ophthalmology, University Medical Center Schleswig-Holstein, University of Lübeck, Lübeck, Germany.; Stålhammar G; Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden; Ocular Oncology Service, St. Erik Eye Hospital, Stockholm, Sweden; St. Erik Ophthalmic Pathology Laboratory, Stockholm, Sweden. Electronic address: gustav.stalhammar@ki.se.
Publisher: Elsevier Country of Publication: England NLM ID: 0045312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1715-3360 (Electronic) Linking ISSN: 00084182 NLM ISO Abbreviation: Can J Ophthalmol Subsets: MEDLINE
Proteau S; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Krossa I; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Husser C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Guéguinou M; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France.; Sella F; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Bille K; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Irondelle M; University Côte d'Azur, Nice, France.; Dalmasso M; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Barouillet T; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France.; Cheli Y; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Pisibon C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Arrighi N; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Nahon-Estève S; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France.; Martel A; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France.; Gastaud L; Centre Antoine Lacassagne, Nice, France.; Lassalle S; University Côte d'Azur, Nice, France.; Laboratory of Clinical and Experimental Pathology, University Hospital of Nice, FHU OncoAge, Cote d'Azur University, Biobank BB-0033-00025, IRCAN team 4, OncoAge FHU, Nice, France.; Mignen O; LBAI, UMR1227, Univ Brest, Inserm, Brest, France.; Brest P; University Côte d'Azur, Nice, France.; IRCAN team 4, Inserm, CNRS, FHU-oncoAge, IHU-RESPIRera, Nice, France.; Mazure NM; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Bost F; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Baillif S; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France.; Landreville S; Département d'ophtalmologie et d'ORL-CCF, Faculté de médecine, Université Laval, Quebec City, QC, Canada.; CUO-Recherche and Axe médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.; Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC, Canada.; Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC, Canada.; Turcotte S; Cancer Axis, Centre de recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montréal, QC, Canada.; Hepato-Pancreato-Biliary Surgery and Liver Transplantation Service, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.; Hasson D; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Carcamo S; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Vandier C; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France.; Bernstein E; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Yvan-Charvet L; University Côte d'Azur, Nice, France.; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France.; Levesque MP; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Ballotti R; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Bertolotto C; University Côte d'Azur, Nice, France. Corine.Bertolotto@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. Corine.Bertolotto@univ-cotedazur.fr.; Strub T; University Côte d'Azur, Nice, France. thomas.strub@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. thomas.strub@univ-cotedazur.fr.
Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Razlog E; Ophthalmology Department, Robert Debre University Hospital, Reims, France.; Denoyer A; Ophthalmology Department, Robert Debre University Hospital, Reims, France.; Baillif S; Ophthalmology Department, Pasteur 2 University Hospital, Nice, France.; Arndt C; Ophthalmology Department, Robert Debre University Hospital, Reims, France.; Dubernard X; ENT Department, Robert Debre University Hospital, Reims, France.; Caujolle JP; Ophthalmology Department, Pasteur 2 University Hospital, Nice, France.; Nahon-Esteve S; Ophthalmology Department, Pasteur 2 University Hospital, Nice, France.; Martel A; Ophthalmology Department, Pasteur 2 University Hospital, Nice, France.
Publisher: Informa Healthcare Country of Publication: England NLM ID: 8610759 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5205 (Electronic) Linking ISSN: 08820538 NLM ISO Abbreviation: Semin Ophthalmol Subsets: MEDLINE
Academic Journal
Journal francais d'ophtalmologie. 45(7)
Academic Journal
Baillif S; Department of Ophthalmology, Pasteur 2 University Hospital, Université Côte-d'Azur, Nice, France; Roca Therapeutics, Nice, France. Electronic address: baillif.s@chu-nice.fr.; Nahon-Esteve S; Department of Ophthalmology, Pasteur 2 University Hospital, Université Côte-d'Azur, Nice, France.; Pace-Loscos T; Centre Antoine Lacassagne, Department of Epidemiology, Biostatistics and Health Data, Nice, France.; Pagès G; Roca Therapeutics, Nice, France; France Institute for Research on Cancer and Aging (IRCAN), Université Côte d'Azur, CNRS UMR 7284 and INSERM U1081, Nice, France.; Dufies M; Roca Therapeutics, Nice, France; France Institute for Research on Cancer and Aging (IRCAN), Université Côte d'Azur, CNRS UMR 7284 and INSERM U1081, Nice, France.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005353 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0023 (Electronic) Linking ISSN: 10434666 NLM ISO Abbreviation: Cytokine Subsets: MEDLINE
Academic Journal
Proteau S; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Krossa I; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Husser C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Guéguinou M; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France.; Sella F; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Bille K; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Irondelle M; University Côte d'Azur, Nice, France.; Dalmasso M; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Barouillet T; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France.; Cheli Y; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Pisibon C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Arrighi N; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Nahon-Estève S; University Côte d'Azur, Nice, France.; Department of Ophthalmology, Centre Hospitalier Universitaire of Nice, Nice, France.; Martel A; University Côte d'Azur, Nice, France.; Department of Ophthalmology, Centre Hospitalier Universitaire of Nice, Nice, France.; Gastaud L; Centre Antoine Lacassagne, Nice, France.; Lassalle S; University Côte d'Azur, Nice, France.; Laboratory of Clinical and Experimental Pathology, University Hospital of Nice, FHU OncoAge, Cote d'Azur University, Biobank BB-0033-00025, IRCAN team 4, OncoAge FHU, Nice, France.; Mignen O; LBAI, UMR1227, Univ Brest, Inserm, Brest, France.; Brest P; University Côte d'Azur, Nice, France.; IRCAN team 4, Inserm, CNRS, FHU-oncoAge, IHU-RESPIRera Nice, Nice, France.; Mazure NM; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Bost F; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Baillif S; University Côte d'Azur, Nice, France.; Department of Ophthalmology, Centre Hospitalier Universitaire of Nice, Nice, France.; Landreville S; Département d'ophtalmologie et d'ORL-CCF, Faculté de médecine, Université Laval, Quebec City, QC, Canada.; CUO-Recherche and Axe médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.; Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC, Canada.; Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC, Canada.; Turcotte S; Cancer Axis, Centre de recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montréal, QC, Canada.; Hepato-Pancreato-Biliary Surgery and Liver Transplantation Service, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.; Hasson D; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Carcamo S; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Vandier C; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France.; Bernstein E; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Yvan-Charvet L; University Côte d'Azur, Nice, France.; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France.; Levesque MP; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Ballotti R; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Bertolotto C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.; Strub T; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.
Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Nahon-Esteve, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어